For dissemination in Canada and over Canadian news services only TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Arias Resource Capital Fund IV L.P. ("ARCF IV") announced that it has agreed to invest US$1,299,999.68 (the "Investment") in units ("Units") of Largo Inc. ("Largo" or the "Issuer") (TSX:LGO) (NASDAQ:LGO). This transaction is part of Largo’s previously announced US$5.7 million registered direct offering (the "Offering"). ARCF IV agreed to purchase 2,321,428 Units of Largo at a price of US$0.56 per Unit. Each Unit consists of one common share ("Common Share") in the capital of Largo and one common Share purchase warrant ("Warrant"). Each Warrant has an exercise price of US$0.70 per W
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- ARCF IV Participates in US$5.7 million Registered Direct Offering
- FLOWERS FOODS ISSUES RECALL OF NATURE'S OWN HAWAIIAN BREAD DUE TO UNDECLARED MILK
THOMASVILLE, Ga., Oct. 2, 2026 /PRNewswire/ -- Flowers Foods, Inc. (NYSE:FLO) is recalling Nature's Own® Hawaiian Bread, 20 oz. and 40 oz. bags, due to undeclared milk. People who have an allergy or severe sensitivity to milk may run the risk of an allergic reaction if they consume this product.The product being recalled was distributed to retail customers in Arkansas, Louisiana, New Mexico, Oklahoma, and Texas.Following is information about the product involved in the recall. People allergic to milk should not consume this product if the "Best if used by" date, UPC and/or Product Code below are printed on the package.PRODUCT DESCRIPTIONUPC #PRODUCT CODES"BEST IF USED BY"Nature's Own® Hawaii
- Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition", "ACI", or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors (the "Compensation Committee") granted inducement awards consisting of nonstatutory stock options to purchase 6,000 shares of common stock to a new non-executive employee under the Company’s 2026 Inducement Grant Plan. The 2026 Inducement Grant Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of the Company. The Compensation Committee approved the st
- Silvercorp Reports 2026 Annual General and Special Meeting Results
Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, Oct. 2, 2026 /CNW/ -- Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX:SVM) (NYSE:SVM) is pleased to report that all matters submitted to shareholders for approval as set out in the Company's Notice of Meeting and Information Circular, both dated August 12, 2026, and the news releases issued on September 22 and September 30, 2026, were approved by the requisite majority of votes cast at Silvercorp's annual general and special meeting (the "Meeting") held today. A total of 123,182,474 common shares, representing 55.69% of the votes attached to all outstanding shares as at the record date for the Meeting, were represented at th
- Electra Reports Quarterly Update on Capital Markets Activity
TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ:ELBM, TSXV:ELBM) ("Electra" or the "Company") reported on its capital markets activity for the previous quarter, including activity under its at-the-market equity program ("ATM") and equity participation by employees and directors. The Company’s equity participation programs support alignment between employees, directors and shareholders through market-based equity ownership. Under the Company’s Employee Share Purchase Program ("ESP"), a total of 37,341 common shares ("Common Shares") were purchased by employees during the third quarter, with a corresponding 37,341 Common Shares acquired by the Compan
- F3 Issues Common Shares Debt Settlement of Interest Owed
Kelowna, British Columbia--(Newsfile Corp. - October 2, 2026) - F3 Uranium Corp. (TSXV:FUU) (OTCQB:FUUFF) (FSE: GL7) ("F3" or the "Company") notes that it wishes to issue common shares to Denison Mines Corp. ("Denison") (TSX:DML) (NYSE:DNN) pursuant its financing agreement as entered into in October 2023. Denison has elected to settle a portion of the accrued interest for the past quarter with the acceptance of common shares of F3 (the "Debt Settlement").The payment to Denison will consist of a cash payment of $225,000 and a total of 797,872 common shares of F3 with a calculated deemed price of $0.141 per share being the 20-day VWAP of the shares as at September 28, 2026.Original Terms of th
- Provident Financial Services, Inc. Schedules Third Quarter Earnings Conference Call
ISELIN, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) announced that it expects to release financial results for the quarter ended September 30, 2026 on Wednesday, October 28, 2026 after market close. A copy of the earnings release will be immediately available on the Company’s website, www.Provident.Bank, by going to Investor Relations and clicking on Press Releases. Representatives of the Company will hold a conference call for investors on October 29, 2026 at 10:00 a.m. (ET) to discuss the Company’s third quarter financial results. Information about the conference call is as follows: PARTICIPANT DIAL-IN NUMBERS Meeting ID (required for call acce
- KinderCare Announces Board of Directors Transitions
Mike Nuzzo steps down; David Barse to head Audit Committee; Preston Grasty rejoins Board KinderCare Learning Companies, Inc. ("KinderCare") (NYSE:KLC), a leading provider of high-quality early childhood education and care, today announced that Mike Nuzzo has resigned from the company’s Board of Directors, effective Sept. 28, due to other personal and professional time commitments. David Barse, who joined KinderCare’s Board on Aug. 3, replaces Nuzzo as the Head of the Audit Committee. Preston Grasty, Senior Investment Leader at Partners Group, has rejoined the Board, effective Sept. 29. "On behalf of the entire Board and KinderCare, I want to thank Mike for his years of dedicated servi
- Almonty Secures Corrective Disclosure from Pure Tungsten Following Successful Settlement Confirming Tiger Kim Held No Leadership Role at Almonty at Any Time
Almonty Industries Inc. ("Almonty" or the "Company") (NASDAQ:ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today noted that Pure Tungsten Inc. ("Pure Tungsten") has published a clarification on its website regarding Mr. Tiger Kim’s prior involvement with Almonty (the "Corrective Disclosure"), accessible at https://www.puretungsten.ca/news-1/pure-tungsten-clarification-of-tiger-kims-prior-involvement-with-almonty-industries. The Corrective Disclosure follows legal proceedings commenced by Almonty in the Ontario Superior Court of Justice on October 10, 2025 in which Almonty sought, among other things, an order compelling Pure Tungsten to issue corrective disclos
- First Hawaiian to Report Third Quarter 2026 Financial Results on October 23, 2026
HONOLULU, Oct. 02, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ:FHB) announced today that it plans to release its third quarter 2026 financial results on Friday, October 23, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time). To access the call by phone, participants will need to click on the following registration link: https://register-conf.media-server.com/register/BI4e0abe37ecf34f5d8bdacfb166cade22, register for the conference call, and then you will receive the dial-in number and a personalized PIN code. To avoid delays, we encourage participants to dial i
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on October 1, 2026, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options and restricted stock units for an aggregate of 352,170 shares of its common stock to 60 new employees under Xeris’ Inducement Equity Plan. Xeris’ Inducement Equity Plan is used exclusively for the grant of equity awards to individuals who were not previously employed by Xeris or one of its subsidiaries as an inducement material to such individual's enteri
- VOYA ASIA PACIFIC HIGH DIVIDEND EQUITY INCOME FUND AND VOYA EMERGING MARKETS HIGH DIVIDEND EQUITY FUND ANNOUNCE TRADING SUSPENSION IN ADVANCE OF REORGANIZATIONS
Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE:VOYA), announced today that shareholders of Voya Asia Pacific High Dividend Equity Income Fund (NYSE:IAE) ("IAE Fund") and Voya Emerging Markets High Dividend Equity Fund (NYSE:IHD) ("IHD Fund," and together with IAE Fund, the "Target Funds") approved the reorganization of each Target Fund with and into Voya Multi-Manager Emerging Markets Equity Fund ("MM EME Fund" or the "Surviving Fund") (each, a "Reorganization" and together, the "Reorganizations") at a combined special meeting of shareholders held on September 28, 2026. Subject to the satisfaction of the remaining closing conditions, the Reorganiza
- Shift4 Announces Fifth Dividend Date for Mandatory Convertible Preferred Stock
Shift4 Payments, Inc. ("Shift4" or the "Company") (NYSE:FOUR), announced today, in connection with the 10,000,000 shares of 6% Series A Mandatory Convertible Preferred Stock issued on May 5, 2025, consistent with the terms laid out in the offering, the Board of Directors has declared a dividend of $1.50 per share to be paid in cash on November 2, 2026 to holders of record as of the close of business on October 15, 2026. Subject to the terms of the Mandatory Convertible Preferred Stock, and as described further in the prospectus supplement filed by the Company with the Securities and Exchange Commission on May 2, 2025, the declaration and payment of future quarterly dividends, if any, will
- Pinnacle West Sets Date for 2026 Third-Quarter Financial Results, Webcast/Conference Call
Pinnacle West Capital Corp. (NYSE:PNW) announced today that it plans to release its 2026 third-quarter financial results before U.S. financial markets open on Tuesday, Nov. 3, 2026. That same day at 11 a.m. (9 a.m. Arizona time), management will host a live webcast and conference call to discuss financial results and recent developments. To access the live session: Join the webcast at www.pinnaclewest.com/presentations for audio of the call and slides; or Dial (888) 506-0062 or (973) 528-0011 for international callers and enter participant access code 904565. To access the replay: Visit www.pinnaclewest.com/presentations within 30 days for the webcast recording; or An aud
- iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
SAN FRANCISCO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC) today provided an update regarding the cybersecurity incident previously disclosed in June 2026. Following completion of the forensic investigation and subsequent review to determine the nature of the impacted data, the company has begun notifying impacted individuals. As previously disclosed, on or around June 8, 2026, iRhythm detected unauthorized access in certain third-party-hosted business applications. Upon detecting the unauthorized access, iRhythm promptly implemented its incident response plan. As part of the investigation, iRhythm has been working very closely with external cybersecurity profes
- AtlasClear Holdings Announces Long-Term Stock Option Awards to Support Leadership Retention and Shareholder Alignment
TAMPA, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE:ATCH) ("AtlasClear" or the "Company"), a company building regulated financial infrastructure for smaller institutions, fintechs and advisors, today announced that its Compensation Committee and Board of Directors approved long-term stock option awards for members of the Company’s executive leadership team and Board of Directors. The awards granted to the Company’s Board of Directors consist of stock options to purchase 626,881 shares of the Company’s common stock each, granted on October 1, 2026 under the AtlasClear Holdings, Inc. 2024 Equity Incentive Plan, as amended, which was previously approved by the Comp
- Pershing Square Declares Fourth Quarter 2026 Dividend
Pershing Square Inc. (NYSE:PS) ("Pershing Square" or the "Company") today announced that its Board of Directors (the "Board") has declared a quarterly cash dividend of $0.103 per share of its common stock for the fourth quarter of 2026, payable on October 20, 2026 to shareholders of record as of the close of business on October 12, 2026. The declaration and amount of any future quarterly cash dividends are at the sole discretion of the Board and may be variable from quarter to quarter. The Board may change the Company's dividend policy at any time, including by reducing or discontinuing the payment of dividends, and there can be no assurance that the Company will pay dividends in any futu
- Catheter Precision to Change its Name and Ticker Symbol to Flyte Aviation and “VJET” and Effect 1-for-10 Reverse Stock Split, Monday, October 5, at Market Open
FORT MILL, S.C., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) (the "Company"), today announced its Board of Directors has approved changing its name and ticker symbol to Flyte Aviation, Inc. and "VJET," respectively. Additionally, the Company will effect a one-for-ten reverse stock split -- as had been approved by stockholders at a Special Meeting of Stockholders April 15, 2026. Every ten shares of common stock will be combined into one share, reducing the outstanding shares from approximately 21.0 million to approximately 2.1 million, with no change to the par value or authorized shares. The reverse stock split will not alter any stockholder’s percentage owner
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on October 1, 2026 (the "Grant Date"), ORIC granted a total of 161,550 non-qualified stock options and 26,850 restricted stock units to six new non-executive employees who began their employment with ORIC in September 2026. These inducement grants were granted pursuant to the ORIC Pharmaceuticals, Inc. 2022 Inducement Equity Incentive Plan, subject to recipient’s continued employment or service through each applicable vesting date. The
- ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (NASDAQ:IMA) ("Imagene" or the "Company") today announced that on September 30, 2026, the Compensation Committee of the Company’s Board of Directors (the "Compensation Committee") granted inducement awards consisting of 90,775 restricted stock units ("RSUs") and 32,725 non-qualified stock options ("NSOs") to three newly hired non-executive employees. The foregoing inducement awards were granted as inducements material to the new employees entering into employment with Imagene in accordance with Nasdaq Listing Rule 5635(c)(4), and are subject to the terms and conditions of the Company’s 2025 Equity Inducement Plan and the applica